Petra Pharma is a clinical-stage pharmaceutical company dedicated to developing novel therapies for serious medical conditions such as cancer and metabolic diseases. Founded in 2016 and based in New York, USA, Petra Pharma focuses on targeting essential cellular processes, including cell division, growth, trafficking, and signaling, through unique enzyme targets. The company's innovative approach involves the development of small molecules aimed at addressing these cellular processes to have a therapeutic impact on human health. Petra Pharma recently secured a $27.55M Debt Financing investment on 15 April 2020. With its pioneering efforts and strategic focus, Petra Pharma presents a compelling opportunity for potential venture capital interest.
General Information
Get notified when Petra Pharma moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Petra Pharma
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
Biotechnology
About Petra Pharma
Taxonomy: Pharmaceuticals, Therapeutics, Cancer Treatment, Metabolic Disorders, Cellular Processes, Enzyme Targets, Small Molecules, Clinical-Stage, New York, Innovative Therapies, Drug Development, Medical Research, Healthcare Innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Debt Financing | •••••• | - | 15 Apr 2020 | |
| Series A | •••••• | 10 |
|
06 Jan 2016 |
Petra Pharma Alternatives & Competitors
Innovate to win. Thinking differently is in the DNA of Petra
As a leading petroleum trading company, Petra Oil DMCC is an integral part of the Buhari Group, one...
Environmental Engineering and Building Waterproofing Services and Consulting
FAQ About Petra Pharma
Don't just browse. Track.
Signal Tracker monitors Petra Pharma and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.